Publisher
Nature Publishing Group on behalf of the European Molecular Biology Organization
History
2005–present
Website
http://www.nature.com/msb/index.html
Impact factor
9.667 (2010)

Some content from Wikipedia, licensed under CC BY-SA

'Living medicine' created to tackle drug-resistant lung infections

Researchers have designed the first "living medicine" to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria that is naturally resistant to many types of antibiotics and is a common source ...

A building block for liver fitness in old age

The liver can regenerate even in old age and remains surprisingly fit, even though the chromatin in its cells undergoes major remodeling due to epigenetic changes, as researchers from the Max Planck Institute for Biology ...

Analyzing the potential of AlphaFold in drug discovery

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming. One promising new strategy is to use computational ...

How cells correctly choose active genes

It is essential for cells to control precisely which of the many genes of their genetic material they use. This is done in so-called transcription factories, molecular clusters in the nucleus. Researchers of Karlsruhe Institute ...

'Living medicine' created to treat drug-resistant infections

Researchers at the Centre for Genomic Regulation (CRG) and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created ...

Finding coronavirus's helper proteins

A group of scientists led by EMBL's Mikhail Savitski, Nassos Typas, and Pedro Beltrao, and collaborator Steeve Boulant at Heidelberg University Hospital, have analyzed how the novel coronavirus affects proteins in human cells. ...

page 1 from 6